These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8069725)

  • 1. [Point mutation of K-ras gene in pancreatic carcinoma].
    Huang YT; Yang YM; Liu Q
    Zhonghua Yi Xue Za Zhi; 1994 Feb; 74(2):77-9, 125-6. PubMed ID: 8069725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
    Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
    Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
    Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.
    Tada M; Omata M; Kawai S; Saisho H; Ohto M; Saiki RK; Sninsky JJ
    Cancer Res; 1993 Jun; 53(11):2472-4. PubMed ID: 8495407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue].
    Cui Q; Wang Z; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of K-ras mutations by denaturing gradient gel electrophoresis (DGGE): a study on pancreatic cancer.
    Pellegata NS; Losekoot M; Fodde R; Pugliese V; Saccomanno S; Renault B; Bernini LF; Ranzani GN
    Anticancer Res; 1992; 12(5):1731-5. PubMed ID: 1444240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of ras oncogene mutation in the human tumor xenografts through serial passages.
    Kijima H; Abe Y; Yamazaki H; Ohnishi Y; Ueyama Y; Tamaoki N; Nakamura M
    Anticancer Res; 1994; 14(6B):2583-7. PubMed ID: 7872685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.
    Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M; Kitamura T; Ohigashi H; Ishikawa O; Takenaka A; Ishiguro S
    Am J Gastroenterol; 1996 Aug; 91(8):1616-21. PubMed ID: 8759672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of K-ras codon 12 point mutation in pancreatic juice in the diagnosis of carcinoma of the pancreas.
    Kimura W; Zhao B; Futakawa N; Muto T; Makuuchi M
    Hepatogastroenterology; 1999; 46(25):532-9. PubMed ID: 10228857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
    Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
    Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
    Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
    Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of point mutation of Kirsten ras oncogene in pancreatic carcinoma by polymerase chain reaction].
    Motojima K; Kohara N; Furui J; Terada M; Tsunoda T; Nagata Y; Urano K
    Nihon Geka Gakkai Zasshi; 1991 Apr; 92(4):453-8. PubMed ID: 1870574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma.
    Lee J; Jang KT; Ki CS; Lim T; Park YS; Lim HY; Choi DW; Kang WK; Park K; Park JO
    Cancer; 2007 Apr; 109(8):1561-9. PubMed ID: 17354229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
    Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assay design and optimization of mutant-enriched PCR based method for detection of K-ras gene mutations in pancreatic carcinoma.
    Ugorcáková J; Hlavatý T; Babál P; Janega P; Bukovská G; Halgasová N; Hlavatá A; Timko J; Duris I
    Neoplasma; 2006; 53(5):363-71. PubMed ID: 17013530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
    Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.